,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #hehh  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,octob] #ac1 #bjbj,mr4
 ,hudson 7= himself & ,ms4 ,blunt       
,ro*e/]7 introduc$ ! foll[+ bill2 :i* 0 
ref]r$ to ! ,committee on ,en]gy &      
,comm]ce1 & 9 addition to ! ,committee  
on ,=eign ,affairs1 = a p]iod to be     
subsequ5tly det]m9$ by ! ,speak]1 9 ea* 
case = consid]ation ( su* provisions z  
fall )9 ! jurisdiction ( ! committee    
conc]n$  ,a ,,bill  ,to provide = a /udy
 on ! curr5t & hi/orical production (   
drugs 9 ! ,unit$ ,/ates & 9 =eign       
c\ntries1 & = o!r purposes4  #a4 ,%ort  
title ,?is ,act may be cit$ z ! ,improv+
 ! ,am]ican ,drug ,supply ,*a9 ,act (   
#bjbj4  #b4 ,/udy & report+ on dome/ic &
 =eign production  7a7 ,9 g5]al ,!      
,secret>y ( ,heal? & ,human ,s]vices    
%all ent] into an agreem5t ) ! ,national
 ,academies ( ,sci5ces1 ,eng9e]+1 &     
,m$ic9e 7ref]r$ to 9 ?is section z !    
,national ,academies7 "u :i*1 n lat] ?an
 #bd mon?s aft] ! date ( enactm5t ( ?is 

,act1 ! ,national ,academies w-- 7#a7   
/udy ! curr5t & hi/orical production (  
drugs & key +r$i5ts !re( 7includ+ active
 ph>maceutical +r$i5ts7 9 ! ,unit$      
,/ates & 9 =eign c\ntries2  7#b7 =mulate
 recomm5dations = promot+ increas$      
production ( drugs & key +r$i5ts !re(   
7includ+ active ph>maceutical +r$i5ts7 9
 ! ,unit$ ,/ates2 &  7#c7 9 a mann] t   
does n compromise national security or  
disclose trade secrets or o!r           
confid5tial comm]cial in=mation t is    
subject to section #eeb7;b77#d7 ( title 
#e1 ,unit$ ,/ates ,code1 or section     
#aije ( title #ah1 ,unit$ ,/ates ,code1 
submit a report to ! ,congress on-- 7,a7
 ! f9d+s & conclusions ( ! /udy "u      
p>agraph 7#a72 &  7,b7 ! recomm5dations 
"u p>agraph 7#b74  7b7 ,/udy topics ,!  
/udy pursuant to subsection 7a77#a7 %all
 include-- 7#a7 evaluation (-- 7,a7 !   
ext5t to :i* production ( drugs = use 9 
! ,unit$ ,/ates & key +r$i5ts !re(      
7includ+ active ph>maceutical +r$i5ts7  
takes place 9 ! ,unit$ ,/ates2 &  7,b7 !

 ext5t to :i* su* production takes place
 9 =eign c\ntries2  7#b7 id5tification (
 ! =eign c\ntries 9 :i* su* production  
takes place2  7#c7 evaluation (         
hi/orical *anges 9 ! c\ntries 9 :i* su* 
production takes place2  7#d7           
det]m9ation ( ! reasons :y su*          
production takes place 9 =eign c\ntries1
 includ+ :y su* production takes place 9
 p>ticul> =eign c\ntries1 includ+       
consid]ation (-- 7,a7 ! reasons =       
hi/orical migration ( su* production to 
=eign c\ntries1 or f =eign c\ntries to  
o!r =eign c\ntries or ! ,unit$ ,/ates2  
7,b7 economic factors1 includ+ economic 
imp$im5ts to dome/ic production &       
inc5tives = =eign production2 &  7,c7   
regulatory1 intellectual prop]ty1       
int]national trade1 & o!r legal & policy
 factors2 &  7#e7 evaluation ( ! b5efits
 ( r$undancies 9 ! supply *a9 ( drugs 9 
! ,unit$ ,/ates 9 ! ev5t ( a public     
heal? em]g5cy4  7c7 ,recomm5dations ,!  
agreem5t "u subsection 7a7 %all-- 7#a7  
provide = inclusion 9 ! recomm5dations  

"u subsection 7a77#b7 ( measures 7:i*   
may include /atutory1 regulatory1 & o!r 
policy *anges7 t %\ld be tak5-- 7,a7 to 
enc\rage ! dome/ic production ( drugs = 
use 9 ! ,unit$ ,/ates & key +r$i5ts !re(
 7includ+ active ph>maceutical +r$i5ts72
 or  7,b7 to o!rwise r$uce ! risks to ! 
availability ( drugs 9 ! ,unit$ ,/ates 9
 ! ev5t ( a public heal? em]g5cy2 &     
7#b7 require consid]ation1 9 develop+   
su* recomm5dations1 (-- 7,a7 factors    
affect+ ! production ( drugs1 includ+-- 
7i7 access to skill$ labor2  7ii7 ! co/ 
( raw mat]ials1 ! co/ ( en]gy1 & relat$ 
co/s2  7iii7 taxes & o!r inc5tives2 &   
7iv7 ! effects ( regulations2 &  7,b7 ! 
co/s & consequ5ces ( implem5t+1 or fail+
 to implem5t1 ea* su* recomm5dation4    
7d7 ,input ,! agreem5t "u subsection 7a7
 %all require-- 7#a7 consid]ation (     
input f ! ,dep>tm5t ( ,heal? & ,human   
,s]vices1 ! ,dep>tm5t ( ,comm]ce1 &1 z  
appropriate1 o!r ,f$]al ag5cies2 &  7#b7
 consultation ) relevant /akehold]s1    
:i*-- 7,a7 may include conduct+ public  

meet+s & o!r =ms ( engagem5t1 z         
appropriate2  7,b7 %all include         
consultation ) exp]ts 9-- 7i7 !         
manufactur+ ( drugs2  7ii7 ph>maceutical
 indu/ry bus9ess & economics2  7iii7    
drug pur*as+1 pric+1 & reimbursem5t2    
7iv7 regulatory & intellectual prop]ty  
issues affect+ drug manufactur+2  7v7   
economics2  7vi7 int]national trade     
policy2 &  7vii7 em]g5cy plann+2 &  7,c7
 may include consultation ) o!r entities
 ) exp]i5ce 9 drug manufactur+ & pric+1 
z appropriate4  7e7 ,def9itions ,9 ?is  
section1 ! t]m drug has ! mean+ giv5 su*
 t]m 9 section #bja ( ! ,f$]al ,food1   
,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4  
#cba74